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Integrin α2β1 in nonactivated 
conformation can induce focal 
adhesion kinase signaling
Maria Salmela1, Johanna Jokinen1,2, Silja Tiitta1, Pekka Rappu1, R. Holland Cheng  2 & Jyrki 
Heino1
Conformational activation of integrins is generally required for ligand binding and cellular signalling. 
However, we have previously reported that the nonactivated conformation of α2β1 integrin can also 
bind to large ligands, such as human echovirus 1. In this study, we show that the interaction between 
the nonactivated integrin and a ligand resulted in the activation of focal adhesion kinase (FAK) in a 
protein kinase C dependent manner. A loss-of-function mutation, α2E336A, in the α2-integrin did not 
prevent the activation of FAK, nor did EDTA-mediated inactivation of the integrin. Full FAK activation 
was observed, since phosphorylation was not only confirmed in residue Y397, but also in residues 
Y576/7. Furthermore, initiation of downstream signaling by paxillin phosphorylation in residue Y118 
was evident, even though this activation was transient by nature, probably due to the lack of talin 
involvement in FAK activation and the absence of vinculin in the adhesion complexes formed by the 
nonactivated integrins. Altogether these results indicate that the nonactivated integrins can induce 
cellular signaling, but the outcome of the signaling differs from conventional integrin signaling.
The well-established model of integrin function stresses the importance of the conformational change from a 
nonactivated, bent conformation to an active, extended state prior to ligand binding and outside-in signaling1. 
Despite the fact that the conformational activation of integrins is often required for ligand binding, nonactivated 
integrins may have specific biological functions as well. Recently, matrix fibrillogenesis was shown to be sup-
pressed by inactive α5β1 integrins2, and in addition inactive αvβ3 has been reported to interact with cell-surface 
protein Thy-13. Furthermore, our previous data suggested that under shear stress, α2β1 integrin binds to collagen 
I without the conformational preactivation of the receptor4. Additionally, ligand-independent signaling mecha-
nisms have recently been found. They can be activated by the interaction of integrins with other transmembrane 
proteins, such as urokinase-type plasminogen activator receptor5.
According to the conventional model of integrin outside-in signaling, the conformational changes in the 
ligand binding inserted domain (αI domain, often called as αA domain), and consequently in the βI domain, lead 
to the separation of integrin legs, including transmembrane and intracellular domains. This allows intracellular 
signaling molecules to interact with integrins, which then initiates the formation of focal adhesion sites6. One 
of the first signaling events is the autophosphorylation of tyrosine residues 397 in focal adhesion kinase (FAK)7. 
The molecular mechanisms leading to the activation of FAK are complex and have yet remained in many parts 
unresolved8, 9. It has recently been shown that FAK activation requires its recruitment to the cell membrane, con-
formational changes in FAK to discontinue the autoinhibition, and the dimerization of two FAK molecules10–12. 
Following the phosphorylation of Y397, interaction with Src induces the phosphorylation of additional tyrosine 
residues, Y576 and Y577, leading to full activation of FAK and to the further FAK interaction with other signaling 
molecules13, 14.
We have previously showed that human echovirus 1 (EV1) binds with a higher avidity to the closed than to the 
open αI domain in the α2β1 integrin. Similarly, EV1 favours the nonactivated, presumably bent α2β1 over the 
preactivated integrin. Moreover, EV1 binding does not seem to cause a conformational change in α2β1, whereas 
one virus particle can cluster several integrins together15. This gave us an opportunity to utilize the interaction 
between EV1 and α2β1 integrin to analyse the signaling mechanisms related to nonactivated integrins.
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In this study we show that the ligand binding and clustering of the nonactivated α2β1 integrins can activate 
FAK and paxillin. We report that the adhesion site generated by the nonactivated α2β1 integrins is different when 
compared to the conventional focal adhesions mediated by integrin binding to the extracellular matrix. FAK acti-
vation by the nonactivated integrins is talin-1 independent and it can be affected by PKC inhibitors. Furthermore, 
the phosphorylation of paxillin seems to be transient in nature, unlike after cell adhesion to collagen I.
Results
The phosphorylation of FAK is initiated by the nonactivated α2β1 integrin. To study the inter-
action between cell and EV1, SaOS cells were plated on a layer of immobilized EV1 particles. This experimental 
design was selected, instead of the use of cell monolayers exposed to virus particles, because it allowed us to study 
cells without the disturbance from other concomitantly occurring integrin mediated matrix adhesion mecha-
nisms. We have previously shown, that Chinese Hamster Ovary cells overexpressing the α2 integrin can attach to 
immobilized layer of EV115. Here, the α2 integrin transfected SaOS cells (SaOSα2+) were able to spread on EV1, 
unlike the α2β1 negative wild type SaOS cells (SaOSα2−) (Fig. 1a). No SaOS cells attached on the plates coated 
with 0.1% BSA (Fig. 1a). The results are in accordance with the previous observations indicating that α2β1 is the 
only cellular receptor for EV116, 17. Based on the confocal microscopy and immunofluorescence utilizing specific 
antibodies, the α2β1 integrin is located at the tips of the cellular protrusions, suggesting that these are the main 
plasma membrane areas involved in the EV1 interaction with the cell (Fig. 1b). Integrin β1 subunit also colocal-
ized with α2 subunit (Fig. S1a). Cells spreading on an EV1 layer did not form clear focal adhesions, or actin stress 
fibers. Rather, actin formed thin, unorganized structures (Fig. S1b). EV1 was further covalently crosslinked on 
a glass surface to reduce the softness of the matrix. Even in the more rigid environment, the nonactivated inte-
grins could not induce the formation of the focal adhesions or the actin stress fibers (Fig. S1c). Smaller physical 
forces mediated by cell-ECM adhesions and modulating the intracellular molecular interactions could explain 
the observation.
Western blot analysis of the SaOSα2+ cells plated on an EV1 layer showed that the tyrosine residue Y397 
in FAK is phosphorylated in less than 15 min and that the phosphorylation level increases up to 60 min. The 
activation was statistically significant. Up to 60 min, the time schedule and magnitude of FAK phosphorylation 
was similar to SaOSα2+ cells spreading on a collagen I (Figs 1c, S2). At later time points (up to 120 min), FAK 
activation on EV1 seemed to decline, whereas on collagen I the activation stayed high (Fig. 1d). We also tested 
the phenomenon in another cell line, the HeLa Ohio that expresses endogenous α2 integrin and can also act as 
EV1 host cell. FAK activation could be detected when these cells were plated on an EV1 coated surface (Fig. 1e). 
We also verified that the activation of FAK is dependent on the receptor-mediated adhesion. In accordance with 
the previously published reports18, the levels of phosphorylated FAK were much lower in the cells plated on a 
poly-L-lysine (Fig. 1f) than in cells plated on a collagen I or an EV1 coated surface (Fig. 1c), and did not gradually 
increase. Cell adhesion to poly-l-lysine is integrin independent and does not induce integrin dependent signaling.
The phosphorylation of FAK is initiated in the conditions that are known to constrain integrin 
to the bent conformation. To confirm that the α2β1 integrins initiating the activation of FAK are in the 
nonactivated conformation, we first introduced the mutation E336A into the α2 subunit and created a SaOS cell 
line overexpressing this variant integrin (SaOSα2E336A)15. Based on the previous observations, the corresponding 
mutations in αL and αM integrins shifts the balance in integrin conformation towards the bent state19, 20. We have 
earlier reported that in α2 subunit, E336A is a loss-of-function mutation which prevents the conformational acti-
vation of the α2β1 integrin21. We confirmed by the flow cytometric analysis equal α2 integrin expression levels 
in the SaOSα2+ and SaOSα2E336A cells (Fig. S3a). We also confirmed that overexpressed α2 pairs with β1 integrins 
in SaOS cells (Fig. S3b). The SaOSα2E336A cells (Fig. 2a) spread on an EV1 coated surface similarly to the SaOSα2+ 
cells (Fig. 1a). Cells did not spread on surfaces coated with BSA (Fig. 2a). Importantly, SaOSα2E336A adhesion to 
EV1 activated the Y397 phosphorylation in FAK (Fig. 2b). Moreover, in conditions where the nonactivated con-
formation of the integrin was further induced by the loss-of-function mutation, the activation of FAK was clearly 
transient and declined after 30 min. The phosphorylation of FAK by the nonactivated integrins was further con-
firmed by treating the cells with 5 mM EDTA prior to plating them on an EV1 layer or a collagen I coated surface. 
The extended conformation of the integrin α-subunit leg is considered to be dependent on the presence of Ca2+ 22 
and therefore EDTA can keep the integrins in the bent state. Here, SaOSα2+ cells treated with EDTA could attach 
and spread on an EV1 layer but not on collagen I (Fig. 2c). Accordingly, a previous study showed that the EDTA 
treatment does not prevent the adhesion of EV1 particles to the cell surface23. Both SaOSα2+ and SaOSα2E336A cells 
showed FAK activation on an EV1 coated cell culture plate in the presence of 5 mM EDTA (Fig. 2d). Cells were 
not tested on a collagen I, since they did not adhere to collagen in the presence of EDTA. Thus, we conclude that 
the loss-of-function mutation of integrins or the inhibition of integrins with EDTA, both known to promote the 
bent conformation, do not prevent the ability of integrins to activate FAK.
The nonactivated α2β1 integrins initiate the formation of the atypical adhesion sites in which 
FAK activation is talin-1 independent, but requires the PKC activity. To test whether the activation 
of FAK by the nonactivated integrins is dependent on the cytoplasmic domain of the α2 subunit, we swapped the 
intracellular tail from α2 to α1 and expressed the variant integrin in the SaOS cells24. Equal α2 integrin expres-
sion levels in the SaOSα2+ and SaOSα2/α1tail cells were confirmed by flow cytometric analysis (Fig. S4a). We did not 
observe any changes in FAK activation after swapping the integrin tails (Fig. S4b). The short intracellular tails of 
the integrin α subunits have not been reported to directly bind to FAK, whereas previous studies have showed 
that FAK can directly bind to the integrin β tails25. Thus, in our model system it is probable that the intracellular 
interactions of the integrin β subunits are responsible for the phosphorylation of FAK.
www.nature.com/scientificreports/
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We used confocal microscopy to analyse whether talin-1 or other focal adhesion proteins can be detected in 
the cellular protrusions mediating the adhesion to EV1. Immunostaining with the specific antibodies indicated 
that talin-1 is present in the same areas at the cell protrusions where α2 integrin is found (Fig. 3a), but failed 
to show densely packed focal adhesion like structures. We also immunostained other selected focal adhesion 
proteins, α-actinin and vinculin, and visualized their colocalization with the nonactivated α2 integrins. In the 
EV1-induced cellular protrusions, α-actinin colocalized with α2 similarly to talin-1, but we could not see the 
colocalization of α2β1 integrin with vinculin (Fig. 3a). In addition to playing a critical role in the formation of 
focal adhesion plaques and in integrin outside-in signaling, talin also activates integrins26. Therefore, the presence 
of talin-1 in the adhesion sites formed by the nonactivated integrins bound to EV1, was an unexpected observa-
tion. The lack of vinculin, however, indicates that the talin conformation does not support the interaction with 
Figure 1. Cells expressing α2 integrin attach on EV1 coated surface through interaction between nonactivated 
integrins and the virus, and activate FAK signaling. (a) Integrin α2 transfected SaOS cells (SaOSα2+) and α2 
integrin negative wild type SaOS cells (SaOSα2−) spreading on EV1 or BSA coated surface. Photographed 
through a phase contrast microscope after 0, 20, 40, and 60 min. Scale bar 50 μm. (b) Confocal microscopy 
image of SaOSα2+ cell on EV1-coated surface. α2 integrins were labelled using specific antibodies. Scale bar 
50 μm. (c) Western blotting detection of phosphorylation of FAK at Y397 in SaOSα2+ cells on collagen I or an 
immobilized layer of EV1. Typical experiment on the left, and on the right, a visualization of the results from ten 
independent experiments presented in box blot as natural logarithm of pY397FAK band intensity normalized 
to β-actin. Whiskers present minimum and maximum of all of the data. Non-parametric Mann-Whitney U 
test was used to determine statistical significance. (d) Western blotting analysis of FAK Y397 phosphorylation 
SaOSα2+ cells plated on collagen I or an immobilized layer of EV1, time points 0 to 120 min. (e) Western blotting 
of FAK Y397 phosphorylation in HeLa OHIO cells plated on collagen I or an immobilized layer of EV1. (f) 
Western blotting of FAK Y397 phosphorylation in SaOSα2+ cells spreading on Collagen I or poly-L-lysine.
www.nature.com/scientificreports/
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vinculin. Thus, talin is not stretched in a manner that would unveil its cryptic vinculin binding sites27. This could 
explain the lack of conventional focal adhesions and actin stress fibers on an EV1 layer (Fig. S1b,c).
To study further the putative interaction between talin and the nonactivated α2β1 integrin, we analysed 
SaOSα2+ and SaOSα2E336A cells plated on collagen I. Wild type SaOS cells are negative for the α2 integrin, but they 
express other collagen receptor integrins, e.g. α1β1 and α11β1 that can mediate cell binding to collagen in the 
absence of the α2 integrin28. According to the confocal microscopy images, variant integrin α2E336A, unlike α2, 
did not participate in the formation of focal adhesion sites, but was mainly located in other plasma membrane 
areas (Fig. 3b) in a very similar manner as was seen in the cells plated on EV1 (Fig. 3a). Based on the quantitative 
image analyses performed with the BioimageXD software29, we detected the colocalization of wild type α2β1 
with talin-1, α-actinin and vinculin, whereas α2E336A colocalized with talin-1 and α-actinin, but clearly less 
with vinculin (Fig. 3b,c). Furthermore, α2E336A did not localize to vinculin positive focal adhesions (Fig. 3c). 
Thus, there seems to be spatial association between the nonactivated, presumably bent α2β1 integrin and talin-1 
although we have no evidence supporting direct protein–protein interaction. Importantly, the data support the 
Figure 2. FAK is activated through α2 integrins harboring the loss-of-function mutation E366A in the α2 
subunit, and in the presence of EDTA. (a) SaOS cells with the loss-of-function mutation E336A in the α2 
subunit (SaOSα2E336A) on EV1-coated surface. Photographed through a phase contrast microscope after 0, 
20, 40, and 60 min. Scale bar 50 μm. (b) Western blot analysis of pY397FAK in SaOSα2E336A cells plated on 
EV1. Typical experiment on the left, and on the right, a visualization of the results from four independent 
experiments presented in box blot as natural logarithm of pY397FAK band intensity normalized to β-actin. 
Whiskers present minimum and maximum of all of the data. Non-parametric Mann-Whitney U test was used 
to determine statistical significance. (c) Phase contrast microscopy images of SaOSα2+ cells treated with integrin 
inactivating EDTA (5 mM) after spreading for 60 min on an immobilized layer of EV1 or collagen I. Scale bar 
50 μm. (d) Western blot analysis of pY397FAK in SaOSα2+ and SaOSα2E336A cells treated with 5 mM EDTA and 
plated on an immobilized layer of EV1.
www.nature.com/scientificreports/
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idea that the adhesion sites formed by the interaction between the nonactivated integrin and EV1 are distinct 
compared to conventional focal adhesions. In the atypical adhesion sites, talin-1 does not sense the physical forces 
as it should as a link protein between integrins and actin microfilaments.
Talin may also be a critical factor in the activation of FAK. It is supposed to recruit FAK to the focal adhesions9, 14  
together with paxillin10 and membrane-bound PIP211. In the next series of experiments we created a lentivirus 
harbouring a talin-1 shRNA construct and used it to silence talin-1 expression in SaOSα2+ cells (Fig. 3d). In three 
independent experiments, the absence of talin-1 did not affect the activation of FAK mediated by the α2β1–
EV1 interaction (Fig. 3d), indicating that FAK activation by nonactivated integrins is not talin-1 dependent. 
Figure 3. Protein interaction with nonactivated α2 integrins. (a) Confocal microscopy images of SaOSα2+ cells 
plated on EV1 coated cell culture plate showing talin-1, α-actinin, vinculin and α2-integrin localization. Scale 
bar 50 μm. (b) Confocal microscopy images of SaOSα2+ and SaOSα2E336A cells plated on collagen I showing talin-
1, α-actinin, vinculin and α2-integrin localization. Scale bar 50 μm. (c) Measurement of the localization of talin 
1, α-actinin and vinculin to α2 integrin positive areas in confocal microscopy images similar to images shown 
in B (10–20 images from three independent experiments, analysed with BioImageXD). Statistical significance 
was calculated with unpaired Student’s t-test. (d) Western blotting of Y397 phosphorylation of FAK in talin 
1 silenced SaOSα2+ cells spreading on an immobilised layer of EV1. Talin 1 was silenced with two different 
shRNAs, and as a control, one nontarget shRNA and one shRNA able to silence FAK were used. (e,f) Western 
blotting of Y397 phosphorylation of FAK in SaOSα2+ cells spreading on EV1 after treatment with PKC inhibitor 
safingol (e; 10 μM, 30 min, n = 4) or Rac inhibitor NSC23766 (f; 100 μM, 1 h, n = 4). Data are presented as box 
blot where whiskers present minimum and maximum values. The p value from paired one-tailed Student’s t-test 
is shown.
www.nature.com/scientificreports/
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A previous report proposes that at least in nascent adhesions talin is not required in the initial phase of FAK 
phosphorylation30.
We have previously shown that EV1 interaction with the α2 integrin activates PKC-α signaling in host 
cells, and that the activity of both PKC-α and Rac1 are required for the uptake of EV1‒integrin complex in a 
micropinocytosis-like mechanism15, 31, 32. Here, we repeated these experiments and showed that the chemical 
inhibitors for PKC (Safingol) and Rac1 (NSC 23766) prevented EV1 cell entry (Fig. S5a,b). Previously, PKC-α 
has been indicated to activate FAK33. To test these pathways in the regulation of FAK, we treated cells with the 
Rac1 and PKC-α inhibitors prior to the plating of the cells on an EV1 coated surface. Safingol reduced FAK acti-
vation in four independent experiments (p = 0.03, Fig. 3e). The inhibition of PKC-α has been reported to prevent 
cell spreading, however, in our experiments the 30 min treatment did not yet reduce cell spreading remarkably 
(Fig. S5c). The Rac1 inhibitor neither reduced cell spreading on EV1 (Fig. S5c), nor had any effect on the activa-
tion of FAK (p = 0.48, Fig. 3f), suggesting that Rac1 is downstream of FAK also when FAK signaling is initiated 
by the nonactivated integrins.
The adhesion mediated by the nonactivated integrins leads to a transient paxillin phospho-
rylation. FAK autophosphorylation at Y397 allows Src first to bind to FAK and then to phosphorylate the 
residues Y576 and Y577 in FAK. Fully activated FAK can then bind and phosphorylate other focal adhesion pro-
teins14. In our model system we could detect that the interaction between α2 integrin and EV1 also induces the 
phosphorylation of Y567 and Y577 in FAK (Fig. 4a). We could also detect the phosphorylation of FAK Y925 and 
Figure 4. Nonactivated integrins induce full FAK activity. Western blotting of the phosphorylation of tyrosines 
576/577 (a) and 925 (b) in FAK, tyrosine 416 in Src (c), and tyrosine 118 in paxillin (d) in SaOSα2+ cells 
plated on collagen I and on EV1. (e) Paxillin phosphorylation normalized to actin from three independent 
experiments described in (d). Figure shows mean values of activation and standard deviation at 0, 30 and 
60 min time points.
www.nature.com/scientificreports/
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Src Y416 (Fig. 4b,c). Paxillin is one of the most important proteins interacting with activated FAK34, and indeed, 
we observed the phosphorylation of Y118 in paxillin when SaOSα2+ cells were plated on an EV1 coated surface 
(Fig. 4d). On collagen I, the phosphorylation of paxillin increased up to 60 min, whereas on EV1 the activation 
started to decline after 30 min (p = 0.05, difference between EV1 and COL I at 60 min time point, Fig. 4e). Thus, 
the nonactivated integrins can induce the full activation of FAK, but the downstream signaling events are tran-
sient by nature.
Discussion
In the nonactivated conformation, integrin legs are together and the head piece of the receptor is facing the 
plasma membrane due to the bending of the legs at the “knee” sites. The bent integrin conformation was first 
described with β3 and β2 integrins and recently also β1 integrins have been supposed to take a similar state before 
the inside-out activation35. Previous papers have suggested that the nonactivated integrin conformations are not 
inactive, but can participate in biologically important functions. Integrins with the closed αI domains may medi-
ate leukocyte rolling36 and, furthermore, bent collagen receptors on platelets bind to collagen I under shear stress 
conditions4. Recently, integrins in the bent conformation have also been linked to the regulation of fibronectin 
fibrillogenesis2, 3. The ligand interactions by the nonactivated integrins can be structurally explained by the flexi-
ble nature of the receptors. This is most evident in the nine out of 18 human integrin α subunits which recognize 
their ligands with an αI domain. According to the atomic structure of αXβ2 integrin, the αI domain seems to 
be quite flexibly bound to the head piece of the receptor and it may therefore reach ligands, even if the rest of the 
integrin is in a bent conformation37. Here, this study focuses on the α2β1, a collagen receptor, that also has an αI 
domain. Based on the in vitro experiments utilizing recombinant collagen-recognizing αI domains, the proteins 
in the closed, nonactivated conformation can bind to their ligands with a relatively high avidity38–42, again sug-
gesting that the nonactivated integrin conformation does not prevent the ligand recognition.
The closed conformation integrin α2I domain can bind to EV1 with higher avidity than the activated, open 
conformation α2I domain15. Similarly, α2 integrin harbouring a loss-of-function E336A mutation is a better 
receptor for EV1 than the α2 integrin that contains a gain-of-function E318W mutation15. Therefore, we have 
suggested that α2β1–EV1 interaction model can be used to study the biology of nonactivated integrins in general. 
In this paper we report, that nonactivated α2β1 integrin can initiate a process leading to the autophosphorylation 
of Y397 in FAK. Four lines of evidence presented in this paper support the idea that no preactivation of integrins 
was needed: Firstly, FAK was phosphorylated after integrin binding to EV1, a ligand that we have previously 
shown to favour the nonactivated integrin conformation and not to induce the conformational activation of the 
receptors15. Secondly, a loss-of-function mutation E336A in the α2 integrin subunit did not prevent FAK activa-
tion. This is the mutation that is considered to keep the integrin in nonactivated conformation19, 20. Thirdly, EDTA 
did not prevent FAK activation, despite the fact that the absence of divalent cations has been reported to force the 
integrin to take the bent conformation22. Fourthly, here FAK phosphorylation took place in the absence of talin, 
a protein that is usually required for the integrin inside-out activation26.
EV1 has 60 potential α2I domain binding sites of which up to 10 sites can be simultaneously occupied, and 
therefore EV1 is capable of receptor clustering15, 43. Our previous reports have also speculated that clustering 
of the nonactivated α2β1 may alone be sufficient to activate signaling proteins such as PKC-α32. Accordingly, 
clustering of FAK proteins in a test tube and in cellular models leads to the autophosphorylation of Y39710. In 
addition, FAK can be activated by clustering antibodies for β1 integrins44. However, EV1 induced, nonactivated 
α2β1 integrin mediated FAK activation cannot be directly compared to the previously reported activation of 
FAK by clustering antibodies, since unlike EV115 the antibodies may also cause a conformational activation of β1 
integrins44.
In several cancers both FAK45 and α2β1 integrin46 transcription are enhanced. Elevated FAK phosphorylation 
has been reported to protect cancer cells from anoikis47 whereas increased α2β1 integrin expression has been 
found in cancer stem cells48, 49. Loss of FAK has also been shown to reduce cancer stem cell population in breast 
cancer50. Both FAK and α2β1 integrin overexpression promote cell migration, invasiveness and EMT45, 46. FAK 
can be activated in cancer cells through increased intracellular pH that leads to deprotonation of histidine residue 
58, enhanced growth factor receptor signaling, increased matrix stiffness, and due to spontaneous dimerization 
and autophosphorylation45. Integrin clustering is, however, the most common mechanism to activate FAK. Thus, 
it is possible to speculate that ligand independent clustering of highly expressed integrins may lead to the activa-
tion of FAK in cancer cells. Our observations support such hypothesis, since we show that integrins can activate 
FAK through integrin clustering and without conformational activation.
Importantly, FAK activation after EV1–α2β1 interaction differs from the conventional activation mechanism 
seen after integrin binding to the ECM molecules. Firstly, the cell adhesion site seems to be different in its appear-
ance in confocal microscopy and also in its molecular composition. The loose structures at the tip of cellular 
protrusions mediating the attachment to EV1 contained talin-1 and α-actinin, but not vinculin. The lack of 
vinculin in the adhesions and the lack of manifest microfilaments in the adherent cells suggest that talin is not 
bridging integrins to polymerized actin in a similar manner as in the conventional focal adhesions. Interestingly, 
one previous report indicates that the mechanism of FAK activation induced by the interaction between α2β1 
integrin and collagen may have fundamental differences when compared to FAK phosphorylation initiated by the 
interaction between fibronectin and its receptor, since the first one is independent of mechanical tension but the 
latter is not12.
Here, FAK activation was talin-1 -independent, but required the activity of PKC. The mechanism of FAK acti-
vation during the formation of conventional focal adhesions is still unclear. The presently predominating working 
model stresses the role of talin9, 14. Here, the observation that talin-1 did not participate in FAK activation was 
not surprising given the fact that the role of talin in the formation of the adhesion site was clearly different when 
compared to the canonical focal adhesions. Furthermore, even in nascent adhesions FAK can be recruited to 
www.nature.com/scientificreports/
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integrin adhesions without talin30. The inhibition of FAK phosphorylation by PKC inhibitors has been shown 
earlier33, 51, 52. However, their effect may in many model systems be indirect and due to e.g. reduced cell spreading. 
Interestingly, both PKC-α53 and FAK25, 54 can also directly bind to β1 integrin cytoplasmic tail. Therefore, integrin 
clustering may bring the two kinases in close contact with each other.
Another difference between FAK activation by the nonactivated and conventionally activated α2 integrins was 
the more transient nature of the first one. We repeatedly observed that FAK phosphorylation started to decline 
after 30 min, especially in the experiments with E366A variant of α2 integrin. The difference in paxillin phospho-
rylation at 60 min time point was even more significant.
To conclude, previous studies have shown that integrins can interact with ligands also without integrin pre-
activation. Here we report that such process can also initiate the phosphorylation of FAK. However, there are 
significant differences when compared to customary FAK activation. After binding to EV1, nonactivated α2β1 
integrins form an atypical adhesion site in which FAK activation takes place via talin-1 -independent mechanism 
that requires PKC activity. Consequent signaling, namely paxillin phosphorylation, is more transient in nature 
than after the formation of conventional focal adhesions.
Materials and Methods
Cell culture. SaOS-2 cells were obtained from ATCC. HeLa OHIO cells, originally from ATCC, were a gift 
from Dr. Petri Susi from department of Virology, University of Turku, Finland. Cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% FCS, 2 mM Ultraglutamine 1, 100 U/ml penicillin 
and streptomycin. SaOS cells were stably transfected with wild type human integrin α2 and loss-of-function 
α2 (α2E336A) as described previously15, 21, 24. SaOS cells were stably transfected with α2/α1-tail that has been 
described earlier24. Transfected cells were grown under geneticin (250 μg/ml) selection.
Echovirus 1. EV1 (Farouk strain, ATCC) was produced at the Department of Virology, University of 
Turku, Finland. EV1 was propagated in LLC cells and purified with sucrose gradient according to Abraham and 
Colonno55. To remove possibly remaining sucrose, virus patch was further purified with dialysis against PBS sup-
plemented with 0.5 mM MgCl2 using Float-A-lyzer (MWCO 50 kDa, Spectrum Laboratories).
shRNA. Talin1 (sh1:TRCN0000299020, sh2:TRCN0000299022) and FAK (TRCN000001617) were silenced 
with lentiviral based RNA interference (Mission shRNA, Sigma). Lentivirus particles were produced using third 
generation production system. pLKO1 plasmid containing the target sequence, together with packaging vec-
tors (pMDL, pREV, pVSVG; Center of Biotechnology, Turku, Finland) were transfected into HEK-293T cells 
with Fugene 6 (Promega). Viral particle containing media was collected and stored in −20 °C. Target SaOS cells 
were infected with 1:1 ratio of fresh DMEM and virus media supplemented with 8 μg/ml polybrene. Media was 
changed the next day and 5 μg/ml puromycin was added the following day to enrich infected cells. Cells were used 
for experiment 96 h after infection.
FAK, Src and paxillin activation on EV1 and collagen I surface. 2.5 μg/cm2 EV1, 5 μg/cm2 Pure Col 
type I bovine collagen (Advanced BioMatrix), or 0.1 mg/ml poly-L-lysine in PBS was incubated on cell culture 
plate overnight at +4 °C, and plates were blocked with 0.1% BSA in PBS for 1 hour at +37 °C. Cells were grown 
in low serum (0.5%) overnight, and where indicated, treated with inhibitors, shRNA, or EDTA. Inhibitors for 
PKC (safingol, 10 µM, 30 min, Calbiochem) and Rac1 (NSC23766, 100 µM, 1 h, Santa Cruz) were added prior cell 
plating and kept during cell adhesion. 5 mM EDTA was added 10 minutes before plating the cells and kept during 
cell adhesion. When detaching the cells for the experiment, trypsin-EDTA was allowed to completely detach the 
cells. Trypsin was inhibited with equal volume of 1 mg/ml trypsin inhibitor, and cells were pelleted and washed, 
and then re-suspended in serum free DMEM. Cells were allowed to attach the virus coated surface for indicated 
time (15–60 min) and lysed for Western blot analysis. Control samples for Western blot (0 min) were pelleted and 
lysed without cell plating.
Analysis of FAK, Src and paxillin activation. Cells were lysed in cold lysis buffer (10 mM Tris-HCl 
pH 7.4; 1% Triton X-100) including protease inhibitors (1 mM EDTA, 10 mM NaF, 10 μg/ml Aprotin, 10 μg/ml 
Leupeptin, 1 mM Na3VO4, 2 mM PMSF, 10 mM Na4P2O7) and phosphatase inhibitor tablet (Roche or Thermo 
Scientific). Lysates were centrifugated at 13000 G for 10 minutes at +4 °C and protein concentrations were 
measured using Bradford reagent (Bio-Rad Laboratories, Inc.). 10 to 30 μg of protein in Laemmli SDS-PAGE 
sample buffer was loaded on gels and proteins were separated with SDS-PAGE electrophoresis. Proteins were 
electrotransferred to nitrocellulose membrane and blocked with blocking buffer (5% milk powder, 1% BSA, 
TBST) for 1 hour. Phospho-FAK primary antibodies (FAK-phospho-Y397, FAK-phospho-Y576/Y577 and 
FAK-phospho-Y925, Cell Signaling), phospho-Src (Src-phospho-Y416, Cell Signaling) and phospho-paxillin 
antibody (paxillin-phospho-Y118) were incubated overnight at +4 °C in 5% BSA in TBST, and secondary anti-
bodies (Horseradish peroxidase conjugated secondary antibodies, Santa-Cruz Biotechnology, Inc.; or Li-COR 
IRDye 680RD/800CW, Li-COR Biosciences) for 1 hour at room temperature in blocking buffer or TBST, respec-
tively. Phospho-antibodies were removed with stripping buffer (Glycine-HCl, 2 times 10 min). Anti-FAK (BD 
Biosciences), anti-paxillin (BD Biosciences) and anti-actin (Santa-Cruz Biotechnology, Inc.) were incubated for 
1 hour in RT. In shRNA silenced cells, also the levels of Talin 1 (Chemicon) were detected. SuperSignal West Pico 
and Femto Chemiluminescent substrate from Thermo Scientific were used to detect the bands with X-Ray-films, 
and Odyssey CLx from Li-COR Biosciences to detect fluorescent secondary antibodies. Band intensities were 
analysed with ImageJ or directly with Odyssey CLx, and phosphorylated FAK/paxillin was proportioned to either 
actin or total FAK/paxillin signal.
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Live imaging. 24-well plates were coated with EV1 and type I collagen as described above, and blocked with 
0.1% BSA. Cells were suspended in serum free DMEM and plated on wells. Images were immediately obtained 
with Zeiss Axiovert 200 M.
Confocal microscopy. For confocal microscopy of cell adhesions, EV1 and type I collagen were coated 
either on 6 cm cell culture plates inside paraffin circle, or on plastic coated glass surface. Cells were allowed to 
attach for 1 hour and then fixed in 4% paraformaldehyde for 20 minutes at room temperature, and permeabi-
lized with 0.2% Triton x-100 in PBS for 5 minutes. Cells attached on cell culture plates were immunolabelled 
in 50 μl drop inside paraffin circle with α2 integrin (rat, clone 430903, R&D Systems), β1 integrin (clone K20, 
sc-18887, Santa-Cruz Biotechnology, Inc.), talin-1 (MAB1676, Chemicon), and vinculin (mouse, Sigma) anti-
bodies where indicated. Alexa-488 or 555 labelled secondary antibodies against mouse and rat (Invitrogen), 
were used. Actin stress fibers were visualized with Alexa-633 conjugated phalloidin (Invitrogen). Mowiol, 
including DABCO (Sigma), was added on top of the cells and high quality 13 mm cover glass was placed 
inside a circle on a cell culture plate. For imaging, the plate was inverted, attached on objective glass from the 
bottom, and imaged with Zeiss LSM 510 confocal microscope. Shown confocal microscopy images are not 
adjusted.
Image analysis. To analyse the colocalization of α2-integrins with talin-1, α-actinin and vinculin, 10 to 20 
SaOSα2+ and SaOSα2E336A cells from three independent experiments were imaged. Image analysis was performed 
with BioImaxeXD batch processor function29. α2-integrin positive areas were defined with threshold function, 
and used as a mask to measure signal intensity of talin-1, α-actinin and vinculin channels in those areas. Talin-1, 
α-actinin and vinculin intensities in α2-positive area were divided by the signal intensity of the protein of interest 
in the total cell area (defined by hand using ROI function).
Statistical analysis. Statistical analysis was performed using IBM SPSS Statistics software version 21. Paired 
Student’s t-test was used to determine the statistical significance of the results when two Western blot timepoints 
or two treatments in confocal microscopy were compared. When several Western blot timepoints were compared, 
the data was analysed with nonparametric Mann-Whitney U test and Bonferroni correction was used to correct 
false discovery rate.
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